NutriStack
Lamotrigine and Methylfolate, a caution.
Lamotrigine is a weak inhibitor of dihydrofolate reductase, though clinical studies show minimal effect on serum or RBC folate in most patients. However, folic acid supplementation may theoretically reduce lamotrigine's anticonvulsant efficacy by counteracting its antifolate mechanism. Paradoxically, animal studies suggest the combination of lamotrigine and folic acid may enhance antidepressant effects and seizure threshold. The clinical significance remains debated.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Lamotrigine and Methylfolate
- Pair type
- Caution
- Evidence (highest tier)
- Moderate
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Moderate evidence
Caution
What is happening. Lamotrigine is a weak inhibitor of dihydrofolate reductase, though clinical studies show minimal effect on serum or RBC folate in most patients. However, folic acid supplementation may theoretically reduce lamotrigine's anticonvulsant efficacy by counteracting its antifolate mechanism. Paradoxically, animal studies suggest the combination of lamotrigine and folic acid may enhance antidepressant effects and seizure threshold. The clinical significance remains debated.
Mechanism. Lamotrigine weakly inhibits dihydrofolate reductase (DHFR), which converts dihydrofolate to tetrahydrofolate. Exogenous folate may partially overcome this inhibition. The anticonvulsant mechanism of lamotrigine is primarily sodium channel blockade, so folate's effect on seizure control through the antifolate pathway is likely minor compared to effects on mood and neural tube defect prevention.
Recommendation. If folate supplementation is needed (particularly in women of childbearing age), use it under prescriber supervision while on lamotrigine. Monitor seizure frequency when starting or changing folate supplementation. Methylfolate may be preferable to folic acid as it bypasses the dihydrofolate reductase step. Do not discontinue lamotrigine or folate without medical guidance.
Sources (2)
- Sander JW et al. An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy. Epilepsy Res. 1992;13(1):89-92. PMID 1425543
- Jain A et al. Effects of folic acid and lamotrigine therapy in some rodent models of epilepsy and behaviour. Methods Find Exp Clin Pharmacol. 2003;25(2):99-103. PMID 12724046
Stack Score
How this pair moves the number.
Effect on the composite score
If both Lamotrigine and Methylfolate are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.